Cyclo Therapeutics
FL - GainesvilleBiotechnology
Focus: Cyclo Therapeutics is a public biotechnology company focused on small molecule therapies for neurological disorders, with a lead program in rare lysosomal storage disease and Alzheimer's disease.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Cyclo Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Cyclo Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Trappsol
Stable
Growth
Lead marketed asset targeting large Alzheimer's indication with 1 active trial.
Pipeline & Clinical Trials
Help build intelligence for Cyclo Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.